Share

January 10, 2017; 88 (2) Resident and Fellow Section

Child Neurology: Neuromyelitis optica spectrum disorders

Michael J. Bradshaw, NgocHanh Vu, Tracy E. Hunley, Tanuja Chitnis
First published January 9, 2017, DOI: https://doi.org/10.1212/WNL.0000000000003495
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1206

Share

Article Information

vol. 88 no. 2 e10-e13
DOI: 
https://doi.org/10.1212/WNL.0000000000003495
PubMed: 
28069981
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published January 9, 2017.
Copyright & Usage: 
© 2017 American Academy of Neurology

Author Disclosures

    1. Michael J. Bradshaw, MD,
    2. NgocHanh Vu, MD,
    3. Tracy E. Hunley, MD and
    4. Tanuja Chitnis, MD
  1. Michael J. Bradshaw, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. NgocHanh Vu, MD,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Tracy E. Hunley, MD and
    4. Scientific Advisory Boards:

    1. I served on a scientific advisory board for Alexion Pharmaceuticals.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Travel to a scientific advisory board meeting of Alexion Pharmaceuticals.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Tanuja Chitnis, MD
    5. Scientific Advisory Boards:

    1. Dr. Chitnis has served on clinical trial advisory boards for Novartis Pharmaceuticals, and Genzyme-Sanofi.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Dr. Chitnis has served as a one-time consultant for Biogen-Idec, Novartis, Genzyme-Sanofi and Genentech-Roche.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Dr. Chitnis receives research support from (1) EMD-Serono, (2) Novartis, (3) Biogen (4) Verily, in the form of Independent Investigator Awards.

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Dr. Chitnis receives research support from the National Multiple Sclerosis Society, the Peabody Foundation, the Consortium for MS Centers and the Guthy-Jackson Charitable Foundation.

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology (M.J.B., N.V.), Vanderbilt University Medical Center; Division of Nephrology and Hypertension (T.E.H.), Vanderbilt Children's Hospital, Nashville, TN; and Center for Neurologic Diseases (T.C.), Brigham and Women's Hospital/Partners MS Center, Brigham and Women's Hospital/Partners Pediatric MS Center, Massachusetts General Hospital, Boston.
  1. Correspondence to Dr. Bradshaw: Michael.j.bradshaw{at}vanderbilt.edu
View Full Text

Article usage

Article usage: January 2017 to December 2022

AbstractFullPdfSource
Jan 20171042658322Highwire
Feb 20171976867Highwire
Mar 2017658150Highwire
Apr 2017554428Highwire
May 2017724032Highwire
Jun 2017502224Highwire
Jul 20171052516Highwire
Aug 2017501612Highwire
Sep 2017571615Highwire
Oct 20171651819Highwire
Nov 20171381116Highwire
Dec 201712310Highwire
Jan 20180279Highwire
Feb 201804510Highwire
Mar 201812917Highwire
Apr 201812710Highwire
May 201811911Highwire
Jun 201802415Highwire
Jul 201812516Highwire
Aug 201813312Highwire
Sep 20181168Highwire
Oct 20180336Highwire
Nov 201813013Highwire
Dec 20180354Highwire
Jan 201912610Highwire
Feb 20190288Highwire
Mar 201932011Highwire
Apr 20194147Highwire
May 201924215Highwire
Jun 20192245Highwire
Jul 20191349Highwire
Aug 201922210Highwire
Sep 20190135Highwire
Oct 201952111Highwire
Nov 201912712Highwire
Dec 201932015Highwire
Jan 20201156Highwire
Feb 20201236Highwire
Mar 20200126Highwire
Apr 20200174Highwire
May 20201158Highwire
Jun 202031810Highwire
Jul 20204115Highwire
Aug 202031514Highwire
Sep 202022110Highwire
Oct 202002412Highwire
Nov 202022313Highwire
Dec 20204175Highwire
Jan 202122222Highwire
Feb 202111512Highwire
Mar 202141514Highwire
Apr 202123114Highwire
May 20212196Highwire
Jun 20212166Highwire
Jul 202111411Highwire
Aug 20212138Highwire
Sep 202111411Highwire
Oct 202151823Highwire
Nov 202131522Highwire
Dec 20210106Highwire
Jan 20220117Highwire
Feb 202222612Highwire
Mar 2022387Highwire
Apr 20220104Highwire
May 202211815Highwire
Jun 20221125Highwire
Jul 20221174Highwire
Aug 2022184Highwire
Sep 2022048Highwire
Oct 2022186Highwire
Nov 20222714Highwire
Dec 2022046Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me